Steroid exposure, acute coronary syndrome, and inflammatory bowel disease: Insights into the inflammatory milieu

American Journal of Medicine

Volumn 128, Issue 3, 2015, Pages 303-311

  Zakroysky, Pearl ^a   Thai, Wai Ee ^a   Deaño, Roderick C ^b   Basnet, Sandeep ^a   Onandia, Zurine Galvan ^a   Gandhi, Sachin ^a   Tawakol, Ahmed ^a   Min, James K ^b   Truong, Quynh A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Acute coronary syndrome; Crohn's disease; Inflammatory bowel disease; Steroids; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; GLUCOCORTICOID; TROPONIN;

ACUTE CORONARY SYNDROME; AGED; BLOOD; CASE CONTROL STUDY; COLITIS, ULCERATIVE; COMPLICATION; CONFIDENCE INTERVAL; CORONARY ANGIOGRAPHY; CROHN DISEASE; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; UNITED STATES;

ACUTE CORONARY SYNDROME; AGED; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CROHN DISEASE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; TROPONIN; UNITED STATES;

EID: 84924067657     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.10.033     Document Type: Article

References (20)

1. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 16 2005 1685 1695
2. G. Rogler Update in inflammatory bowel disease pathogenesis Curr Opin Gastroenterol 20 4 2004 311 317
3. C.N. Bernstein, A. Wajda, and J.F. Blanchard The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study Clin Gastroenterol Hepatol 6 1 2008 41 45
4. J. Haapamaki, R.P. Roine, and U. Turunen Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease J Crohns Colitis 5 1 2011 41 47
5. I. Roifman, P.L. Beck, and T.J. Anderson Chronic inflammatory diseases and cardiovascular risk: A systematic review Can J Cardiol 27 2 2011 174 182
6. M.J. Carter, A.J. Lobo, and S.P. Travis Guidelines for the management of inflammatory bowel disease in adults Gut 53 Suppl 5 2004 V1 V16
7. R. Hayashi, H. Wada, K. Ito, and I.M. Adcock Effects of glucocorticoids on gene transcription Eur J Pharmacol 500 1-3 2004 51 62
8. A.J. Yarur, A.R. Deshpande, and D.M. Pechman Inflammatory bowel disease is associated with an increased incidence of cardiovascular events Am J Gastroenterol 106 4 2011 741 747
9. P.C. Souverein, A. Berard, and T.P. Van Staa Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study Heart 90 8 2004 859 865
10. L. Wei, T.M. MacDonald, and B.R. Walker Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease Ann Intern Med 141 10 2004 764 770
11. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 7152 2007 427 434
12. F. Haverkate, S.G. Thompson, and S.D. Pyke Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Lancet 349 9050 1997 462 466
13. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 2 1999 237 242
14. S.D. Dorn, and R.S. Sandler Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis Am J Gastroenterol 102 3 2007 662 667
15. C. Ha, S. Magowan, and N.A. Accortt Risk of arterial thrombotic events in inflammatory bowel disease Am J Gastroenterol 104 6 2009 1445 1451
16. M.T. Osterman, Y.X. Yang, and C. Brensinger No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease Clin Gastroenterol Hepatol 9 10 2011 875 880
17. A.R. Sridhar, S. Parasa, and U. Navaneethan Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients J Crohns Colitis 5 4 2011 287 294
18. C. Rungoe, S. Basit, and M.F. Ranthe Risk of ischaemic heart disease in patients with inflammatory bowel disease: A nationwide Danish cohort study Gut 62 5 2013 689 694
19. S.L. Kristensen, O. Ahlehoff, and J. Lindhardsen Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death - a Danish nationwide cohort study PLoS One 8 2 2013 e56944
20. B.R. Walker Glucocorticoids and cardiovascular disease Eur J Endocrinol 157 5 2007 545 559